Multiple biomarker assessment in primary prevention of cardiovascular disease

Current Cardiovascular Risk Reports

Volumn 3, Issue 2, 2009, Pages 131-136

  Daniels, Lori B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873494809     PISSN: 19329520     EISSN: 19329563     Source Type: Journal    
DOI: 10.1007/s12170-009-0021-z     Document Type: Article

References (24)

1. Khot UN, Khot MB, Bajzer CT, et al.: Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 2003, 290: 898-904.
2. American Heart Association: Heart Disease and Stroke Statistics - 2008 Update. Dallas, TX: American Heart Association; 2008.
3. Greenland P, Knoll MD, Stamler J, et al.: Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 2003, 290: 891-897.
4. Ware JH: The limitations of risk factors as prognostic tools. N Engl J Med 2006, 355: 2615-2617.
5. Sabatine MS, Morrow DA, de Lemos JA, et al.: Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 2002, 105: 1760-1763.
6. de Lemos JA, Morrow DA: Combining natriuretic peptides and necrosis markers in the assessment of acute coronary syndromes. Rev Cardiovasc Med 2003, 4(Suppl 4): S37-S46.
7. Cannon CP, Greenberg BH: Risk stratification and prognostic factors in the post-myocardial infarction patient. Am J Cardiol 2008, 102: 13G-20G.
8. Wilson PW, D'Agostino RB, Levy D, et al.: Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97: 1837-1847.
9. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106: 3143-3421.
10. Lloyd-Jones DM, Leip EP, Larson MG, et al.: Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 2006, 113: 791-798.
11. Wang TJ, Gona P, Larson MG, et al.: Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006, 355: 2631-2639.
12. Cook NR: Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007, 115: 928-935.
13. Zethelius B, Berglund L, Sundstrom J, et al.: Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008, 358: 2107-2116.
14. Daniels LB, Laughlin GA, Clopton P, et al.: Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study. J Am Coll Cardiol 2008, 52: 450-459.
15. Ridker PM, Buring JE, Rifai N, Cook NR: Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 2007, 297: 611-619.
16. Ridker PM, Paynter NP, Rifai N, et al.: C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds risk score for men. Circulation 2008, 118: 2243-2251, 4p following 2251.
17. Akosah KO, Schaper A, Cogbill C, Schoenfeld P: Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform?J Am Coll Cardiol 2003, 41: 1475-1479.
18. Michos ED, Nasir K, Braunstein JB, et al.: Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women. Atherosclerosis 2006, 184: 201-206.
19. Michos ED, Vasamreddy CR, Becker DM, et al.: Women with a low Framingham risk score and a family history of premature coronary heart disease have a high prevalence of subclinical coronary atherosclerosis. Am Heart J 2005, 150: 1276-1281.
20. Shlipak MG, Fried LF, Cushman M, et al.: Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 2005, 293: 1737-1745.
21. Cohn JN, Duprez DA: Time to foster a rational approach to preventing cardiovascular morbid events. J Am Coll Cardiol 2008, 52: 327-329.
22. Greenland P, Lloyd-Jones D: Defining a rational approach to screening for cardiovascular risk in asymptomatic patients. J Am Coll Cardiol 2008, 52: 330-332.
23. Pepe MS, Janes H, Longton G, et al.: Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 2004, 159: 882-890.
24. Espey DK, Wu XC, Swan J, et al.: Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer 2007, 110: 2119-2152.